SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410578-19-001106
Filing Date
2019-09-09
Accepted
2019-09-09 07:10:50
Documents
51
Period of Report
2019-09-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv529048_8k.htm   iXBRL 8-K 24075
2 EXHIBIT 99.1 tv529048_99-1.htm EX-99.1 65972
6 GRAPHIC tv529048_ex99-1img01.jpg GRAPHIC 217252
7 GRAPHIC tv529048_ex99-1img02.jpg GRAPHIC 293616
8 GRAPHIC tv529048_ex99-1img03.jpg GRAPHIC 267271
9 GRAPHIC tv529048_ex99-1img04.jpg GRAPHIC 221808
10 GRAPHIC tv529048_ex99-1img05.jpg GRAPHIC 199715
11 GRAPHIC tv529048_ex99-1img06.jpg GRAPHIC 226395
12 GRAPHIC tv529048_ex99-1img07.jpg GRAPHIC 253434
13 GRAPHIC tv529048_ex99-1img08.jpg GRAPHIC 228053
14 GRAPHIC tv529048_ex99-1img09.jpg GRAPHIC 231525
15 GRAPHIC tv529048_ex99-1img10.jpg GRAPHIC 208873
16 GRAPHIC tv529048_ex99-1img11.jpg GRAPHIC 231473
17 GRAPHIC tv529048_ex99-1img12.jpg GRAPHIC 212810
18 GRAPHIC tv529048_ex99-1img13.jpg GRAPHIC 433262
19 GRAPHIC tv529048_ex99-1img14.jpg GRAPHIC 228382
20 GRAPHIC tv529048_ex99-1img15.jpg GRAPHIC 213182
21 GRAPHIC tv529048_ex99-1img16.jpg GRAPHIC 207053
22 GRAPHIC tv529048_ex99-1img17.jpg GRAPHIC 218693
23 GRAPHIC tv529048_ex99-1img18.jpg GRAPHIC 206906
24 GRAPHIC tv529048_ex99-1img19.jpg GRAPHIC 226454
25 GRAPHIC tv529048_ex99-1img20.jpg GRAPHIC 186975
26 GRAPHIC tv529048_ex99-1img21.jpg GRAPHIC 234435
27 GRAPHIC tv529048_ex99-1img22.jpg GRAPHIC 268543
28 GRAPHIC tv529048_ex99-1img23.jpg GRAPHIC 212596
29 GRAPHIC tv529048_ex99-1img24.jpg GRAPHIC 207020
30 GRAPHIC tv529048_ex99-1img25.jpg GRAPHIC 233366
31 GRAPHIC tv529048_ex99-1img26.jpg GRAPHIC 222187
32 GRAPHIC tv529048_ex99-1img27.jpg GRAPHIC 224505
33 GRAPHIC tv529048_ex99-1img28.jpg GRAPHIC 218285
34 GRAPHIC tv529048_ex99-1img29.jpg GRAPHIC 203600
35 GRAPHIC tv529048_ex99-1img30.jpg GRAPHIC 208796
36 GRAPHIC tv529048_ex99-1img31.jpg GRAPHIC 209517
37 GRAPHIC tv529048_ex99-1img32.jpg GRAPHIC 215571
38 GRAPHIC tv529048_ex99-1img33.jpg GRAPHIC 214991
39 GRAPHIC tv529048_ex99-1img34.jpg GRAPHIC 214280
40 GRAPHIC tv529048_ex99-1img35.jpg GRAPHIC 206904
41 GRAPHIC tv529048_ex99-1img36.jpg GRAPHIC 226866
42 GRAPHIC tv529048_ex99-1img37.jpg GRAPHIC 161377
43 GRAPHIC tv529048_ex99-1img38.jpg GRAPHIC 233651
  Complete submission text file 0001410578-19-001106.txt   12168400

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tbph-20190909.xsd EX-101.SCH 3193
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbph-20190909_lab.xml EX-101.LAB 33476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbph-20190909_pre.xml EX-101.PRE 21963
47 EXTRACTED XBRL INSTANCE DOCUMENT tv529048_8k_htm.xml XML 3625
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 191080829
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1